Both in Pharmaceuticals
Omeros vs Damora Therapeutics
Over the past year OMER returned −9.5% and DMRA returned −26.4%; their daily moves had a correlation of 0.13.
OMER −9.5% DMRA −26.4%Growth of $1, one year, split-adjusted
| Metric | OMER | DMRA |
|---|---|---|
| Price | $16.55 | $20.67 |
| Market cap | $1.20B | $1.28B |
| Today | +1.22% | +7.27% |
| 1 month | −10.5% | −9.5% |
| 6 months | +24.8% | — |
| Year to date | −3.6% | — |
| 1 year | +104.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 97.2% | — |
| Net margin | 46.4% | — |
| P/E (TTM) | 9.6× | — |
| Price / sales | 31.2× | — |
| Net cash | $58.7M | $540.5M |
| Dividend yield | — | — |
| Volatility (60d) | 75.1% | — |
| Short % of float | 17.7% | 10.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).